Review Test Submission:
Week 11 Final Exam
User
Course NURS-6630D-3/NURS-6630N-3/NURS-6630F-3-
Approaches to Treatment2020 Summer Qtr 06/01-
08/23-PT27
Test Week 11 Final Exam
Status Completed
Attemp 66 out of 75 points
t Score
Time 1 hour, 46 minutes out of 2
Elapse
d hours Submitted Answers
Results
Displaye
d Question 1
•
1 out of 1 points
A patient diagnosed with obsessive compulsive disorder has been taking a high-dose
SSRI and is participating in therapy twice a week. He reports an inability to carry out
responsibilities due to consistent interferences of his obsessions and compulsions. The
PMHNP knows that the next step would be which of the following?
Selected b.
Answer: Decrease his SSRI and add
buspirone (Buspar).
• Question 2
1 out of 1 points
The PMHNP prescribes pregabalin (LYRICA) for a patient with chronic pain. How does
pregabalin work to reduce pain?
Selected c.
Answer: It will block excitatory neurotransmission by blocking voltage-
sensitive calcium channels.
• Question 3
1 out of 1 points
The PMHNP is meeting with the parents of an 8-year-old patient who is receiving an
initial prescription for D-amphetamine. The PMHNP demonstrates appropriate
prescribing practices when she prescribes the following dose:
Selected b.
Answer: The child will be prescribed
, 2.5 mg.
• Question 4
1 out of 1 points
Mike wants to quit smoking. He has tried nicotine replacement and varenicline without
success. He has asked for another medication to help him kick his habit. The PMHNP
decides to try a medication that increases dopamine by prescribing a medications that
can increase both norepinephrine and dopamine. Which medication did the PMHNP
prescribe?
Selected d.
Answer: Bupropion
(ZYBAN)
• Question 5
1 out of 1 points
The PMHNP is teaching a patient with a sleep disorder about taking diphenhydramine
(Benadryl). The patient is concerned about the side effects of the drug. What can the
PMHNP teach the patient about this treatment approach?
Selected c.
Answer: “It can cause blurred
vision.”
• Question 6
1 out of 1 points
Karen completes the Epworth sleepiness scale and scores abnormally high. She is
diagnosed with narcolepsy. The PMHNP prescribes a wake-promoting agent that is a
weak dopamine transporter antagonist. Which medication did the PMHNP prescribe?
Selected a.
Answer: Modafanil
(PROVIGIL)
• Question 7
1 out of 1 points
Heather is admitted for opioid withdrawals and detoxification. The PMHNP decides to
prescribe an alpha-2 adrenergic agonist to reduce the symptoms of autonomic
hyperactivity during withdrawal and aid in the detoxification process. Which medication
did the PMHNP prescribe?
Selected b.
Answer: Clonidin
e
• Question 8
1 out of 1 points
A patient is being prescribed bupropion and is concerned about the side effects. What
, will the PMHNP tell the patient regarding bupropion?
Selected c.
Answer: It can cause cardiac
arrhythmias.
• Question 9
1 out of 1 points
An adult patient presents with a history of alcohol addiction and attention deficit
hyperactivity disorder (ADHD). Given these comorbidities, the PMHNP determines which
of the following medications may be the best treatment option?
Selected b.
Answer: Atomoxetine
(Strattera)
• Question 10
1 out of 1 points
The PMHNP wants to prescribe Mr. Barber a mood stabilizer that will target aggressive
and impulsive symptoms by decreasing dopaminergic neurotransmission. Which mood
stabilizer will the PMHNP select?
Selected a.
Answer: Lithium
(Lithane)
• Question 11
1 out of 1 points
A young patient is prescribed Vyvanse. During the follow-up appointment, which
comment made by the patient makes the PMHNP think that the dosing is being done
incorrectly?
Selected c.
Answer: “I am unable to fall asleep at
night.”
• Question 12
1 out of 1 points
A patient is prescribed D-methylphenidate, 10-mg extended-release capsules. What
should the PMHNP include when discussing the side effects with the patient?
Selected c.
Answer: The medication can affect your blood
pressure.
• Question 13
1 out of 1 points
Jacob is a 7-year-old pediatric patient who has significant oppositional symptoms
Week 11 Final Exam
User
Course NURS-6630D-3/NURS-6630N-3/NURS-6630F-3-
Approaches to Treatment2020 Summer Qtr 06/01-
08/23-PT27
Test Week 11 Final Exam
Status Completed
Attemp 66 out of 75 points
t Score
Time 1 hour, 46 minutes out of 2
Elapse
d hours Submitted Answers
Results
Displaye
d Question 1
•
1 out of 1 points
A patient diagnosed with obsessive compulsive disorder has been taking a high-dose
SSRI and is participating in therapy twice a week. He reports an inability to carry out
responsibilities due to consistent interferences of his obsessions and compulsions. The
PMHNP knows that the next step would be which of the following?
Selected b.
Answer: Decrease his SSRI and add
buspirone (Buspar).
• Question 2
1 out of 1 points
The PMHNP prescribes pregabalin (LYRICA) for a patient with chronic pain. How does
pregabalin work to reduce pain?
Selected c.
Answer: It will block excitatory neurotransmission by blocking voltage-
sensitive calcium channels.
• Question 3
1 out of 1 points
The PMHNP is meeting with the parents of an 8-year-old patient who is receiving an
initial prescription for D-amphetamine. The PMHNP demonstrates appropriate
prescribing practices when she prescribes the following dose:
Selected b.
Answer: The child will be prescribed
, 2.5 mg.
• Question 4
1 out of 1 points
Mike wants to quit smoking. He has tried nicotine replacement and varenicline without
success. He has asked for another medication to help him kick his habit. The PMHNP
decides to try a medication that increases dopamine by prescribing a medications that
can increase both norepinephrine and dopamine. Which medication did the PMHNP
prescribe?
Selected d.
Answer: Bupropion
(ZYBAN)
• Question 5
1 out of 1 points
The PMHNP is teaching a patient with a sleep disorder about taking diphenhydramine
(Benadryl). The patient is concerned about the side effects of the drug. What can the
PMHNP teach the patient about this treatment approach?
Selected c.
Answer: “It can cause blurred
vision.”
• Question 6
1 out of 1 points
Karen completes the Epworth sleepiness scale and scores abnormally high. She is
diagnosed with narcolepsy. The PMHNP prescribes a wake-promoting agent that is a
weak dopamine transporter antagonist. Which medication did the PMHNP prescribe?
Selected a.
Answer: Modafanil
(PROVIGIL)
• Question 7
1 out of 1 points
Heather is admitted for opioid withdrawals and detoxification. The PMHNP decides to
prescribe an alpha-2 adrenergic agonist to reduce the symptoms of autonomic
hyperactivity during withdrawal and aid in the detoxification process. Which medication
did the PMHNP prescribe?
Selected b.
Answer: Clonidin
e
• Question 8
1 out of 1 points
A patient is being prescribed bupropion and is concerned about the side effects. What
, will the PMHNP tell the patient regarding bupropion?
Selected c.
Answer: It can cause cardiac
arrhythmias.
• Question 9
1 out of 1 points
An adult patient presents with a history of alcohol addiction and attention deficit
hyperactivity disorder (ADHD). Given these comorbidities, the PMHNP determines which
of the following medications may be the best treatment option?
Selected b.
Answer: Atomoxetine
(Strattera)
• Question 10
1 out of 1 points
The PMHNP wants to prescribe Mr. Barber a mood stabilizer that will target aggressive
and impulsive symptoms by decreasing dopaminergic neurotransmission. Which mood
stabilizer will the PMHNP select?
Selected a.
Answer: Lithium
(Lithane)
• Question 11
1 out of 1 points
A young patient is prescribed Vyvanse. During the follow-up appointment, which
comment made by the patient makes the PMHNP think that the dosing is being done
incorrectly?
Selected c.
Answer: “I am unable to fall asleep at
night.”
• Question 12
1 out of 1 points
A patient is prescribed D-methylphenidate, 10-mg extended-release capsules. What
should the PMHNP include when discussing the side effects with the patient?
Selected c.
Answer: The medication can affect your blood
pressure.
• Question 13
1 out of 1 points
Jacob is a 7-year-old pediatric patient who has significant oppositional symptoms
